Roles of mast cells in rheumatoid arthritis

키워드

참고문헌 (88)

1. Pitzalis C, "New learnings on the pathophysiology of RA from synovial biopsies", Curr Opin Rheumatol, 25, pp.334~344 (2013)
2. Deane KD, "Editorial : prevention of rheumatoid arthritis : now is the time, but how to proceed", Arthritis Rheumatol, 69, pp.873~877 (2017)
3. Smolen JS, "Rheumatoid arthritis", Nat Rev Dis Primers, 4, pp.18001~ (2018)
4. Aletaha D, "Diagnosis and management of rheumatoid arthritis : a review", JAMA, 320, pp.1360~1372 (2018)
5. Malmstrom V, "The immunopathogenesis of seropositive rheumatoid arthritis : from triggering to targeting", Nat Rev Immunol, 17, pp.60~75 (2017)
6. Crisp AJ, "Articular mastocytosis in rheumatoid arthritis", Arthritis Rheum, 27, pp.845~851 (1984)
7. Xu Y, "Mast cell and autoimmune diseases", Mediators Inflamm, 2015, pp.246126~ (2015)
8. Rivellese F, "Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody production", Ann Rheum Dis, 77, pp.1773~1781 (2018)
9. van de Sande MG, "Different stages of rheumatoid arthritis : features of the synovium in the preclinical phase", Ann Rheum Dis, 70, pp.772~777 (2011)
10. Waldner H, "The role of innate immune responses in autoimmune disease development", Autoimmun Rev, 8, pp.400~404 (2009)
11. Krystel-Whittemore M, "Mast cell : a multi-functional master cell", Front Immunol, 6, pp.620~ (2016)
12. Dahlin JS, "Mast cell progenitors : origin, development and migration to tissues", Mol Immunol, 63, pp.9~17 (2015)
13. Amin K, "The role of mast cells in allergic inflammation", Respir Med, 106, pp.9~14 (2012)
14. Godfrey HP, "Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases", Arthritis Rheum, 27, pp.852~856 (1984)
15. Malone DG, "Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lymphocytic infiltration and modulation by antiinflammatory therapy", Arthritis Rheum, 30, pp.130~137 (1987)
16. Kopicky-Burd JA, "Characterization of human synovial mast cells", J Rheumatol, 15, pp.1326~1333 (1988)
17. Kiener HP, "Expression of the C5a receptor(CD88)on synovial mast cells in patients with rheumatoid arthritis", Arthritis Rheum, 41, pp.233~245 (1998)
18. Ceponis A, "Expression of stem cell factor (SCF) and SCF receptor (c-kit) in synovial membrane in arthritis: correlation with synovial mast cell hyperplasia and inflammation", J Rheumatol, 25, pp.2304~2314 (1998)
19. Olsson N, "Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients", Ann Rheum Dis, 60, pp.187~193 (2001)
20. Tetlow LC, "Distribution, activation and tryptase", chymase phenotype of mast cells in the rheumatoid lesion, 1995, pp.54, 549~555
21. Gotis-Graham I, "Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression", Arthritis Rheum, 40, pp.479~489 (1997)
22. Gotis-Graham I, "Synovial mast cell responses during clinical improvement in early rheumatoid arthritis", Ann Rheum Dis, 57, pp.664~671 (1998)
23. Ramirez J, "Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission", Arthritis Res Ther, 18, pp.74~ (2016)
24. Woolley DE, "Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion", Arthritis Res, 2, pp.65~74 (2000)
25. Tetlow LC, "Effects of induced mast cell activation on prostaglandin E and metalloproteinase production by rheumatoid synovial tissue in vitro", Ann Rheum Dis, 57, pp.25~32 (1998)
26. Lee H, "Activation of human synovial mast cells from rheumatoid arthritis or osteoarthritis patients in response to aggregated IgG through Fcγ receptor I and Fcγ receptor II", Arthritis Rheum, 65, pp.109~119 (2013)
27. Suurmond J, "Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies", Ann Rheum Dis, 74, pp.1915~1923 (2015)
28. Rivellese F, "Ability of interleukin-33-and immune complex-triggered activation of human mast cells to down-regulate monocyte-mediated immune responses", Arthritis Rheumatol, 67, pp.2343~2353 (2015)
29. Martin CA, "Aberrant extracellular and dendritic cell (DC) surface expression of heat shock protein (hsp)70 in the rheumatoid joint: possible mechanisms of hsp", DC-mediated cross-priming, 2003, pp.171, 5736~5742
30. Midwood K, "Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease", Nat Med, 15, pp.774~780 (2009)
31. Gondokaryono SP, "The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4", J Leukoc Biol, 82, pp.657~665 (2007)
32. Okamura Y, "The dual regulation of substance P-mediated inflammation via human synovial mast cells in rheumatoid arthritis", Allergol Int, 66S, pp.S9~S20 (2017)
33. Xu D, "IL-33 exacerbates antigen-induced arthritis by activating mast cells", Proc Natl Acad Sci U S A, 105, pp.10913~10918 (2008)
34. Xu D, "IL-33 exacerbates autoantibody-induced arthritis", J Immunol, 184, pp.2620~2626 (2010)
35. Kashiwakura J, "Interleukin-33synergistically enhances immune complex-induced tumor necrosis factor alpha and interleukin-8 production in cultured human synovium-derived mast cells", Int Arch Allergy Immunol, 161(Suppl 2), pp.32~36 (2013)
36. Binstadt BA, "Particularities of the vasculature can promote the organ specificity of autoimmune attack", Nat Immunol, 7, pp.284~292 (2006)
37. Bridges AJ, "Human synovial mast cell involvement in rheumatoid arthritis and osteoarthritis. Relationship to disease type, clinical activity, and antirheumatic therapy", Arthritis Rheum, 34, pp.1116~1124 (1991)
38. Nent E, "Histamine 4 receptor plays an important role in auto-antibody-induced arthritis", Int Immunol, 25, pp.437~443 (2013)
39. Kim KW, "Histamine and histamine H4 receptor promotes osteoclastogenesis in rheumatoid arthritis", Sci Rep, 7, pp.1197~ (2017)
40. Kroner J, "Mast cells are critical regulators of bone fracture-induced inflammation and osteoclast formation and activity", J Bone Miner Res, 32, pp.2431~2444 (2017)
41. Gruber BL, "Activation of latent rheumatoid synovial collagenase by human mast cell tryptase", J Immunol, 140, pp.3936~3942 (1988)
42. Shin K, "Mast cells contribute to autoimmune inflammatory arthritis via their tryptase", heparin complexes, 2009, pp.182, 647~656
43. McNeil HP, "The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis", Arthritis Rheum, 58, pp.2338~2346 (2008)
44. Denadai-Souza A, "Effect of tryptase inhibition on joint inflammation : a pharmacological and lentivirus-mediated gene transfer study", Arthritis Res Ther, 19, pp.124~ (2017)
45. Zhao L, "Chemerin 156F, generated by chymase cleavage of prochemerin, is elevated in joint fluids of arthritis patients", Arthritis Res Ther, 20, pp.132~ (2018)
46. Chu Y, "Mast cell chymase in synovial fluid of collagen-induced-arthritis rats regulates gelatinase release and promotes synovial fibroblasts proliferation via FAK", p21 signaling pathway, 2019, pp.514, 336~343
47. de Souza Junior DA, "The role of mast cell specific chymases and tryptases in tumor angiogenesis", Biomed Res Int, 2015, pp.142359~ (2015)
48. Norrby K, "Mast cells and angiogenesis", APMIS, 110, pp.355~371 (2002)
49. Hoxha M, "A systematic review on the role of eicosanoid pathways in rheumatoid arthritis", Adv Med Sci, 63, pp.22~29 (2018)
50. Noack M, "Selected cytokine pathways in rheumatoid arthritis", Semin Immunopathol, 39, pp.365~383 (2017)
51. Mathis SP, "Nonredundant roles for leukotriene B4 receptors BLT1 and BLT2 in inflammatory arthritis", J Immunol, 185, pp.3049~3056 (2010)
52. Miyahara N, "Leukotriene B4 release from mast cells in IgE-mediated airway hyperresponsiveness and inflammation", Am J Respir Cell Mol Biol, 40, pp.672~682 (2009)
53. Cho C, "Prostaglandin D2 metabolites as a biomarker of in vivo mast cell activation in systemic mastocytosis and rheumatoid arthritis", Immun Inflamm Dis, 4, pp.64~69 (2015)
54. Sandler C, "Selective activation of mast cells in rheumatoid synovial tissue results in production of TNF-alpha, IL-1beta and IL-1Ra", Inflamm Res, 56, pp.230~239 (2007)
55. Nigrovic PA, "Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1", Proc Natl Acad Sci U S A, 104, pp.2325~2330 (2007)
56. Hueber AJ, "Mast cells express IL-17A in rheumatoid arthritis synovium", J Immunol, 184, pp.3336~3340 (2010)
57. Kan J, "Interleukin-17A expression in human synovial mast cells in rheumatoid arthritis and osteoarthritis", Allergol Int, 65(Suppl), pp.S11~S16 (2016)
58. Guma M, "JNK1 controls mast cell degranulation and IL-1{beta} production in inflammatory arthritis", Proc Natl Acad Sci U S A, 107, pp.22122~22127 (2010)
59. van der Velden D, "Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile", Arthritis Res Ther, 18, pp.138~ (2016)
60. Juurikivi A, "Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia : a potential approach to the treatment of arthritis", Ann Rheum Dis, 64, pp.1126~1131 (2005)
61. Shiota N, "The anti-allergic compound tranilast attenuates inflammation and inhibits bone destruction in collagen-induced arthritis in mice", Br J Pharmacol, 159, pp.626~635 (2010)
62. Gri G, "Mast cell : an emerging partner in immune interaction", Front Immunol, 3, pp.120~ (2012)
63. Palm AK, "Activated mast cells promote differentiation of B cells into effector cells", Sci Rep, 6, pp.20531~ (2016)
64. Stelekati E, "Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions", Immunity, 31, pp.665~676 (2009)
65. Kambayashi T, "Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation", J Immunol, 182, pp.4686~4695 (2009)
66. Suurmond J, "Communication between human mast cells and CD4(+)T cells through antigen-dependent interactions", Eur J Immunol, 43, pp.1758~1768 (2013)
67. Gaudenzio N, "Human mast cells drive memory CD4+ T cells toward an inflammatory IL-22+ phenotype", J Allergy Clin Immunol, 131, pp.1400~1407 (2013)
68. Ott VL, "Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4", Nat Immunol, 4, pp.974~981 (2003)
69. Nakae S, "Mast cells enhance T cell activation : Importance of mast cell-derived TNF", Proc Natl Acad Sci U S A, 102, pp.6467~6472 (2005)
70. Gruber BL, "Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation", J Clin Invest, 84, pp.1657~1662 (1989)
71. Tetlow LC, "Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion : dual immunolocalisation studies", Ann Rheum Dis, 54, pp.896~903 (1995)
72. Sawamukai N, "Mast cell-derived tryptase inhibits apoptosis of human rheumatoid synovial fibroblasts via rho-mediated signaling", Arthritis Rheum, 62, pp.952~959 (2010)
73. Galli SJ, "Immunomodulatory mast cells : negative, as well as positive, regulators of immunity", Nat Rev Immunol, 8, pp.478~486 (2008)
74. Rossini M, "Serum levels of tryptase suggest that mast cells might have an antiinflammatory role in rheumatoid arthritis : comment on the article by Rivellese et al", Arthritis Rheumatol, 68, pp.769~ (2016)
75. Rivellese F, "Reply", Arthritis Rheumatol, 68, pp.769~770 (2016)
76. Magnusson SE, "Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis", FASEB J, 23, pp.875~882 (2009)
77. Heger K, "A20-deficient mast cells exacerbate inflammatory responses in vivo", PLoS Biol, 12, pp.e1001762~ (2014)
78. Lee DM, "Mast cells : a cellular link between autoantibodies and inflammatory arthritis", Science, 297, pp.1689~1692 (2002)
79. Kneilling M, "Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice", Arthritis Rheum, 56, pp.1806~1816 (2007)
80. Reber LL, "New models for analyzing mast cell functions in vivo", Trends Immunol, 33, pp.613~625 (2012)
81. Schubert N, "Mast cell promotion of T cell-driven antigen-induced arthritis despite being dispensable for antibody-induced arthritis in which T cells are bypassed", Arthritis Rheumatol, 67, pp.903~913 (2015)
82. Zhou JS, "Mast cell deficiency in Kit(W-sh)mice does not impair antibody-mediated arthritis", J Exp Med, 204, pp.2797~2802 (2007)
83. Pitman N, "Collagen-induced arthritis is not impaired in mast cell-deficient mice", Ann Rheum Dis, 70, pp.1170~1171 (2011)
84. Grimbaldeston MA, "Mast cell-deficient W-sash c-kit mutant Kit W-sh", W-sh mice as a model for investigating mast cell biology in vivo, 2005, pp.167, 835~848
85. Feyerabend TB, "Cre-mediated cell ablation contests mast cell contribution in models of antibody-and T cell-mediated autoimmunity", Immunity, 35, pp.832~844 (2011)
86. Bluett J, "Precision medicine in rheumatoid arthritis", Rheum Dis Clin North Am, 43, pp.377~387 (2017)
87. Mukai K, "Mast cells as sources of cytokines, chemokines, and growth factors", Immunol Rev, 282, pp.121~150 (2018)
88. Suurmond J, "Human mast cells costimulate T cells through a CD28-independent interaction", Eur J Immunol, 46, pp.1132~1141 (2016)

관련 논문AI추천